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ABDOMINAL fibroids induced in the guinea-pig by a-oestradiol (Nelson, 1937;
Lipschutz and Iglesias, 1939) are prevented when progesterone or other 3-keto-
steroids are administered simultaneously with the oestrogen (Lipschutz and
Vargas, 1941; Lipschutz, 1944; Lipschutz, Iglesias, Bruzzone, Fuenzalida and
Riesco, 1948). The antifibromatogenic action of progesterone becomes manifest
with as little as 13 to 24 ,ug. per day absorbed from a subcutaneously implanted
tablet (Lipschutz, Bruzzone and Fuenzalida, 1944). Since similar abdominal
fibroids have been elicited also with diethylstilboestrol and hexoestrol (Lipschutz
and Vargas, 1940; Lipschutz, Vargas, Egafia and Bruzzone, 1941) the question
arose whether progesterone will be as active against these artificial oestrogens
as against oc-oestradiol. This question is of considerable interest. Nothing
definite is so far known on the mechanism by which the antifibromatogenic
action of steroids is effected. Will the greater resistance of these artificial
oestrogens against intrahepatic inactivation (Zondek, Sulman and Sklow, 1943;
Segaloff, 1944; Lipschutz, Quintana and Bruzzone, 1944) be associated with a
quantitatively different behaviour towards progesterone ?PREVENTION OF ABDOMINAL FIBROIDS 399
EXPERIMENTS.
Tablets containing 40 per cent of diethylstilboestrol or hexoestrol mixed
with 60 per cent of cholesterol were implanted subcutaneously. At the same
time a tablet of pure progesterone or a tablet containing 40 per cent of pro-
gesterone was implanted. Absorption from a similar mixture is non-selective,
the concentration of the specific steroid remaining unaltered (Shimkin and
White, 1941; Fuenzalida, 1944); this refers also to diethylstilboestrol. To
obtain absorption of variable quantities of progesterone half a tablet or less was
implanted in several animals. Results with 96 castrated female guinea-pigs are
given in Table I.
TABLE L.-96 Female Guinea-pigs; Necropsied at 90 Days of Treatment.
Number Weight Frequency of
of Oestrogen Progesterone of F.T.E. tumours class
animals. per day. per day. uterus. Units.t 2 and 3.t
(n.-*) ([Lg** (g.)
Stilboestrol
15 . 6-20 . 0 . 4-9 . 4.9 . 14
14 . 4-20 . 2-9 . 41 . 3.7 . 10
10 . 11-17 . 10-18 . 4 2 . 3 7 . 12
3 . 8-9 . 36-414 . 3-7 . 15 . 0
3 . 7-9 . 60-70$ . 2-3 . 1*3 . 0 7
6 . 7-9 . 85-1041 . 2-6 . 1*8 . 0-3
15§ . 9-21 . 120-3051 . 2-1 . 0'9 . 0.1
Hexoestrol
5 . 3-10 . 0 . 3-9 . 4.3 . 1-4
8 . 4-10 . 10-17 . 3.9 . 2-4 . 0-5
2 . 2-9 . 22-34 . 2-6 . 1-3 . 0
15§ . 8-13 . 122-2611 . 1-7 . 0-4 . 0
* Calculated from the loss of weight of the tablet divided by number of days, on the
assumption of non-selective absorption.
t F.T.E. = Fibrous Tumoural Effect; units according to Lipschutz and Vargas (1939)
and Lipschutz and Maass (1944).
t Tablets of pure progesterone or part of a tablet. In the remaining groups-tablets
containing 40 per cent of progesterone.
§ From experiments of E. Pefia (1943).
There is no doubt that the fibromatogenic action of both diethylstilboestrol
and hexoestrol has been prevented by progesterone; with quantities of 120 ,ug.
or more per day the preventive action of progesterone was as pronounced as in
former experiments with a-oestradiol (Fig. 1).
There was certainly a preventive action also with quantities less than 120 ,ug.
and even with as little as 36 to 41 and 22 to 34 ,ug. respectively, as shown both
by the diminution ofuterine weight and the diminution ofthe tumoural reaction.
Prevention was, indeed, at these levels less complete. But these figures of active
quantities ofprogesterone are not very distant from those obtained in our former
work with the antifibromatogenic action of progesterone against o-oestradiol.
There is also the fact that statements about absorption per day are stultified by
its not being uniform throughout the experiment on account of the diminished
surface, and by substances entering into the tablet from outside; errors are400 S. BRUZZONE
consequently considerable (Folley, 1944). This is why it would be daring to
interpret the present results as indicative of a greater resistance of artificial
oestrogens to the antifibromatogenic action of progesterone.
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FIG. 1.-Antifibromatogenic action of progesterone (122 to 261 [tg. per day) in experiments
with hexoestrol. Horizontal line-average F.T.E. with hexoestrol alone.
SUMMARY.
The fibromatogenic action of diethylstilboestrol and hexoestrol is prevented
by the simultaneous administration of progesterone as is the fibromatogenic
action of oc-oestradiol. The quantity of progesterone necessary for preventing
the fibromatogenic action of these artificial oestrogens, though somewhat greater
than in experiments with a-oestradiol, was not far from that.
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